Jane Street’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-28,497
Closed -$950K 10999
2024
Q3
$950K Sell
28,497
-1,586
-5% -$54.6K ﹤0.01% 6004
2024
Q2
$813K Buy
30,083
+11,545
+62% +$228K ﹤0.01% 6176
2024
Q1
$400K Buy
+18,538
New +$404K ﹤0.01% 7086
2021
Q2
Sell
-10,606
Closed -$174K 10886
2021
Q1
$174K Buy
+10,606
New +$173K ﹤0.01% 8365

Jane Street's LBPH Position: Q4 2024 in Review

Jane Street sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 28,497 shares — an estimated $950K sold.

Jane Street first reported a position in LBPH in Q1 2021 and held it in 4 quarters. The position peaked at $950K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Jane Street reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Jane Street sold 28,497 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $950K.
  • Jane Street first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Jane Street's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $950K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.